A new patent dispute in pharma industries over the weight-loss drug Wegovy (semaglutide) has reached the Delhi High Court. The case involves Hyderabad-based Natco Pharma and Danish pharmaceutical giant Novo Nordisk. Natco Pharma has challenged Novo Nordisk’s patent rights related to Wegovy, marking another legal battle in India’s competitive pharmaceutical sector over high-demand, blockbuster drugs like semaglutide.

https://analystip.com/wegovy-p....atent-case-india-nat